leucine has been researched along with Triple Negative Breast Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Camarda, R; Crawford, LA; Ding, L; Goga, A; Grossman, EA; Huffman, TR; Louie, SM; Miyamoto, DK; Nomura, DK; Weerapana, E | 1 |
1 other study(ies) available for leucine and Triple Negative Breast Neoplasms
Article | Year |
---|---|
GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutathione S-Transferase pi; Humans; Leucine; Mice; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship; Triazines; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2016 |